Open Access

RETRACTED ARTICLE: High doses of garlic extract significantly attenuated the ratio of serum LDL to HDL level in rat-fed with hypercholesterolemia diet

  • Tahereh Ebrahimi1,
  • Behnoosh Behdad2,
  • Maryam Agha Abbasi3, 4,
  • Rahman Ghaffarzadegan Rabati5,
  • Amir Farshid Fayyaz6,
  • Vahid Behnod7 and
  • Ali Asgari8Email author
Diagnostic Pathology201510:74

https://doi.org/10.1186/s13000-015-0322-0

Received: 13 May 2015

Accepted: 12 June 2015

Published: 20 June 2015

The Retraction Note to this article has been published in Diagnostic Pathology 2016 11:119

Abstract

Background

Hypercholesterolemia is associated with an increased risk of heart disease. In this study, we investigated the antihyperlipidemic effects of garlic (Allium sativum L.) in rat models of hypercholesterolemic.

Methods

Wistar male rats were randomly divided into 4 diet groups with garlic supplementation. Male Wistar rats were fed by standard pellet diet (group I), standard diet supplemented with 4 % garlic (group II), lipogenic diet (containing sunflower oil, cholesterol and ethanol) equivalent to 200 mg raw garlic/kg body weight (raw) (group III) and lipogenic diet equivalent to 400 mg raw garlic/kg body weight (raw) (group IV).

Results

Rats fed 400 g/kg garlic extract(GE), had a significantly lower concentration of serum low-density lipoprotein cholesterol (LDL-C) cholesterol and elevated HDL –C cholesterol at day 28 (P < 0.05).In addition,serum levels of LDL-C was lower in the III and IV group than those in the IV group (P < 0.001 for each). However, cholesterol efflux capacity was positively correlated with HDL cholesterol concentration (P < 0 · 0001). It was also directly correlated with garlic supplementation (P < 0 · 0001).

Conclusion

Together Taken, the results are clearly indicative of the beneficial effects of garlic in reducing lateral side effects of hyperlipidemia. Our data demonstrate that GE has protective effects on HDL in rats with high LDL intake. Therefore, it could be used to remedy hypercholesterolemia with help reduce risk of coronary heart disease

Virtual slides

The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1834155749171141

Keywords

GarlicLow density lipoprotein cholesterolHigh density lipoprotein cholesterolRatPharmacology

Background

Hyperlipidemia is a major risk factor involved in ischemic heart disease. The prevalence of hyperlipidemia as well as its complications is increasing in the world. Moreover, alterations in serum lipid and lipoprotein levels result in a variety of chronic diseases such as coronary heart diseases (CHD) and atherosclerosis [1]. CHD is a major health problem in developed countries, and atherosclerosis is the principal contributor to the pathogenesis of myocardial and cerebral infarction [2], which in this case, there is convincing evidence that relaxation mediated by endothelium-derived nitric oxide (NO) is impaired in arteries from hypercholesterolemic and atherosclerotic animals [3, 4]. Many studies have now shown that elevated concentrations of total or LDL cholesterol in the blood are powerful risk factors for CHD [5], whereas high concentrations of HDL cholesterol or a low LDL (or total) to HDL cholesterol ratio may protect against CHD [2, 6].

Recent studies have directed their efforts toward the protective effects of plants such as garlic on hyperlipidemia [7, 8]. During the last few decades, the hypolipidemic effect of garlic and onion has been confirmed by many investigators, and many medications in the market that control hypercholesterolemia and hypertriglyceridemia. There have also been reports on the beneficial effects of garlic extract and oil in controlling hyperlipidemia in animals [713].

Garlic (Allium sativum L.) has long been used widely not only as a flavoring agent but also as a folk medication and is one of the most well-known herbal medicines worldwide and there has been increasing interest in using garlic as a cholesterol-lowering agent. Its reported beneficial actions and its compounds have been reported to have diverse biological activities such as cholesterol and triglyceride-lowering effects [14, 15],antimicrobial [16], antithrombotic [17], antihypertensive [18, 19] and anti-hyperlipidemic effects [20, 21],regulating plasma lipid levels, anti-carcinogenic, lead and mercury detoxification, antioxidant,, anti-diabetic, and various other biological actions [2225]. Also, garlic has cardio-protective effects as it may help decrease TC, LDL- C and blood pressure while raising high HDL [26, 27]. The aim of this study was to evaluate of the anti-hyperlipidemic, and anti-hypercholesterolemic activities of garlic extract (GE) at doses of 200 and 400 mg/kg body weight for 2 and 4weeks, intraperitoneal (i.p.) prior to the induction of HDL/LDL, was investigated against hyperlipidemic/hypercholesterolemic in male rats

Methods

Animals and animal ethics/and or welfare

Forty healthy male Wistar albino rats weighing 200–250 grams were obtained from the Animal Care Center at College of Medicine, Shiraz University. Animals were housed in wire cages(four per cage,and rats were kept in individual propylene cages under standard laboratory conditions by the dimensions of 30 × 50 × 25 cm3 two by two,1 month before the start of the experiments, and maintained under a daily controlled lighting cycle(12 h-light and 12 h-dark) at 22 + 2 °C and 60 % humidity with free access to rat diet and tap water for one week to adapt to the laboratory environment prior to the experiments. Animals were kept for 4 weeks to allow acclimatization to the animal facility before starting the experiments.

All animals received human care according to the criteria outlined in the “Guide for the Care and Use of Laboratory Animals” prepared by the National Academy of Sciences and published by the National Institutes of Health

Preparation of garlic extracts

Garlic bulbs utilized in these studies was purchased from a local grocery herb store in Shiraz, Iran. The garlic powder was prepared from fresh garlic bulb, which was heat-dried at 60–70 °C, and then ground by a mill. Volatile compounds in the garlic powder were analyzed by gas chromatography using daily disulfide as a standard [28, 29]. All garlic derivatives were stored at 4 °C and stocks of the water-soluble compounds were made fresh every time before use. Briefly, garlic cloves were peeled and homogenized with a small amount of quartz sand in 20 mmol/L Tris–HCl buffer (pH 7.4), and the debris was removed by centrifugation at 21,000 × g for 20 min at 25 °C. Subsequently, 30 g and 60 g of the powdered seeds were added to 400 ml and 800 ml of distilled water, and the extraction was obtained by steam distillation. The distillation process was continued until 200 mg/kg and 400 mg/kg of distillate were collected. The distillate was extracted three times with hydro-alcoholic liquid

Experimental protocol/or procedure and treatments

The rats were divided into four groups and randomly allotted into one of four experimental groups each group contained ten animals. The control group was fed a standard diet (normal control)(for first stage 15 days and second stage 30 days) (n = 10), and test animals in group II was fed a standard diet plus 10 % cholesterol-enriched high-fat (U.A.R., Paris, France; hypercholesterolemic controls) (for 2 weeks and 4 weeks) (n = 10);

Groups III and IV, the rats were fed with a lipogenic diet containing standard pellet diet supplemented with 0.5 % (w/w) cholic acid, 20 % (w/w) sunflower oil and 2 % (w/w) cholesterol for at least two weeks to produce hyperlipidemia. Additionally, groups III and IV drank water containing 3 % (v/v) ethanol). Groups III and IV received garlic extract as an intraperitoneal (IP) dose of 200 and 400 mg/kg/bw (for 2 and 4 weeks) (garlic diet, n = 10), respectively. In addition, the garlic extract in experimental group was injected intraperitoneally. Blood samples were collected into test tubes containing EDTA through cardiac puncture. The plasma samples were separated by low speed centrifugation (2000 g) for 10 min and were stored at _80 _C until they were analyzed. All animal procedures were performed with regard to Iranian animal ethics society and local university rules.

Plasma biochemical measurements/and or biochemical assay of serum lipids

Blood samples were taken directly from the heart in a centrifuge tube and allowed to form serum and processed as previously described, however, in each rat was determined after the start the treatment and every 15 d in total 2 times, and or can be expressed that after the 4-weeks treatment, the rats were killed using urethane anesthesia. The blood was collected by cardiac puncture and allowed to clot, and the clotted blood was then centrifuged at 4500 × g for 10 min. The serum was separated and stored at −80 °C for HDL and LDL analysis, and these serum concentrations were determined with commercially available enzyme kits (BioMerieux, Marcy, France).

Statistical analysis

All data are presented as means ± SEM. Statistical analyses were analyzed using one-way ANOVA and two-way ANOVA, and significant differences between means were evaluated by the Tukey’s range post-hoc test compare between experimental groups. Differences with P < 0.05 were considered significant.

Results

The effect of processed garlic on density lipoprotein-cholesterol characteristics is shown in Tables 1, 2, 3, 4, 5 and 6. After 2 and 4 weeks of treatment, LDL-c and HDL-c,decreased and increased significantly in the different groups, compared with control(I) and rats fed a diet enriched with high cholesterol groups(II),respectively, (P < 0.05).
Table 1

Effects of daily administration of garlic extract on plasma LDL profile for 2 and 4 weeks in male albino Wistar rats. The 95 % confidence interval of recalculated

Time

Groups

Mean ± SEM

Lower bound

Upper bound

2wk

Control

18.4000 ± 2.07364

15.8252

20.9748

2wk

hypercholesterolemic controls

25.8000 ± 1.48324

23.9583

27.6417

2wk

dose of 200 mg/kg/bw of garlic extract

21.8000 ± 8.22800

11.5836

32.0164

2wk

dose of 400 mg/kg/bw of garlic extract

19.2000 ± 3.49285

14.8631

23.5369

2wk

Total

85.2000 ± 2.87364

18.5075

22.3591

4wk

Control

11.4000 ± 4.33590

6.0163

16.7837

4wk

hypercholesterolemic controls

24.2000 ± 8.28855

13.9084

34.4916

4wk

dose of 200 mg/kg/bw of garlic extract

22.8000 ± 2.86356

19.2444

26.3556

4wk

dose of 400 mg/kg/bw of garlic extract

16.2000 ± 3.83406

11.4394

20.9606

4wk

Total

41.1000 ± 9.92418

15.3125

20.0342

Table 2

Effects of daily administration of garlic extract on plasma LDL profile for 2 weeks in male albino Wistar rats

Groups

Compared with groups

Mean difference (I-J)

Std. Error

Sig.

Lower bound

Upper bound

1

2

-.80000

2.49933

.999

−8.5278

6.9278

3

4.00000

2.49933

.606

−3.7278

11.7278

4

−7.40000

2.49933

.066

−15.1278

.3278

2

1

6.60000

2.49933

.126

−1.1278

14.3278

3

11.40000

2.49933

.002

3.6722

19.1278

4

7.40000

2.49933

.066

-.3278

15.1278

3

1

2.60000

2.49933

.899

−5.1278

10.3278

2

3.40000

2.49933

.749

−4.3278

11.1278

4

−4.00000

2.49933

.606

−11.7278

3.7278

4

1

−6.60000

2.49933

.126

−14.3278

1.1278

2

.80000

2.49933

.999

−6.9278

8.5278

3

4.80000a

2.49933

.415

−2.9278

12.5278

aSignificant as compared to another groups

Table 3

Effects of daily administration of garlic extract on plasma LDL profile for 4 weeks in male albino Wistar rats

Groups

Compared with groups

Mean difference (I-J)

Std. Error

Sig.

Lower bound

Upper bound

1

2

4.8000

3.05666

.625

−14.2510

4.6510

3

−5.24000*

3.05666

.526

−14.6910

4.2110

4

−12.80000*

3.05666

.004

−22.2510

−3.3490

2

1

12.80000

3.05666

.004

3.3490

22.2510

3

1.40000

3.05666

.997

−8.0510

10.8510

4

8.00000

3.05666

.132

−1.4510

17.4510

3

1

11.40000*

3.05666

.012

1.9490

20.8510

2

6.60000

3.05666

.293

−2.8510

16.0510

4

−1.40000

3.05666

.997

−10.8510

8.0510

4

1

12.80000*

3.05666

.004

3.3490

22.2510

2

8.00000

3.05666

.132

−1.4510

17.4510

3

1.40000

3.05666

.997

−8.0510

10.8510

Table 4

Effects of daily administration of garlic extract on plasma HDL profile for 2 and 4 weeks in male albino Wistar rats. The 95 % confidence interval of recalculated

Time

Groups

Mean ± SEM

Lower bound

Upper bound

2wk

Control

41.4000 ± 3.64692

36.8718

45.9282

2wk

hypercholesterolemic controls

28.0000 ± 4.35890

22.5877

33.4123

2wk

dose of 200 mg/kg/bw of garlic extract

36.6000 ± .89443

35.4894

37.7106

2wk

dose of 400 mg/kg/bw of garlic extract

37.4000 ± 3.64692

32.8718

41.9282

2wk

Total

41.4000 ± 2.96463

34.7494

40.0506

4wk

Control

52.8000 ± 7.19027

43.8721

61.7279

4wk

hypercholesterolemic controls

29.6000 ± 9.39681

17.9323

41.2677

4wk

dose of 200 mg/kg/bw of garlic extract

31.4000 ± 4.33590

26.0163

36.7837

4wk

dose of 400 mg/kg/bw of garlic extract

33.2000 ± 3.27109

29.1384

37.2616

4wk

Total

82.5000 ± 7.20917

34.6368

42.9632

Table 5

Effects of daily administration of garlic extract on plasma HDL profile for 2 weeks in male albino Wistar rats

Groups

Compared with groups

Mean difference (I-J)

Std. Error

Sig.

Lower bound

Upper bound

1

2

13.40000

2.99333

.002

4.1448

22.6552

3

4.80000

2.99333

.604

−4.4552

14.0552

4

4.00000a

2.99333

.763

−5.2552

13.2552

2

1

−13.40000

2.99333

.002

−22.6552

−4.1448

3

−8.60000

2.99333

.079

−17.8552

.6552

4

−9.40000a

2.99333

.045

−18.6552

-.1448

3

1

−4.80000

2.99333

.604

−14.0552

4.4552

2

8.60000

2.99333

.079

-.6552

17.8552

4

-.80000

2.99333

1.000

−10.0552

8.4552

4

1

−4.00000a

2.99333

.763

−13.2552

5.2552

2

9.40000**

2.99333

.045

.1448

18.6552

3

8.0000

2.99333

1.000

−8.4552

10.0552

aSignificant as compared to another groups

Table 6

Effects of daily administration of garlic extract on plasma HDL profile for 4 weeks in male albino Wistar rats

Groups

Compared with groups

Mean difference (I-J)

Std. Error

Sig.

Lower bound

Upper bound

1

2

23.20000

3.97240

.000

10.9176

35.4824

3

21.40000*

3.97240

.000

9.1176

33.6824

4

19.60000*

3.97240

.001

7.3176

31.8824

2

1

−23.20000

3.97240

.000

−35.4824

−10.9176

3

−1.80000*

3.97240

.997

−14.0824

10.4824

4

−3.60000*

3.97240

.941

−15.8824

8.6824

3

1

−21.40000*

3.97240

.000

−33.6824

−9.1176

2

−19.60000*

3.97240

.001

−31.8824

−7.3176

4

1.80000

3.97240

.997

−10.4824

14.0824

4

1

−19.60000*

3.97240

.001

−31.8824

−7.3176

2

−17.80000*

3.97240

.002

−30.0824

−5.5176

3

1.80000

3.97240

.997

−10.4824

14.0824

Plasma lipid profiles of LDL-c level

First stage; between 1–15 days (2 weeks): Tables 1 and 2 shows that between groups 2 and 4 induced a significant increase in serum LDL-C (P <0/05) and a significant decrease in the serum LDL-C level in comparison with the control. Also, between 3 and 4, there is a significant difference (P <0/05) and showed a significant decrease in serum LDL-C level, when compared to that of groups I and II (Fig. 1)(Tables 1 and 2).
Fig. 1

Effect of garlic extracts (200 and 400 mg/kg) on serum LDL levels in comparison with the control and hypercholesterolemic groups for 2 weeks on the activity of LDL. Note that statistically significant difference from the control group with other groups. *Significant as compared to 200 mg/kg group. Bars are expressed as mean ± SEM (n = 10). P < 0.05

Second stage; between 1–30 days (4 weeks): Tables 1 and 3 reveals a significant decrease of serum LDL-C level between groups 1 and 4 (P <0/05). Furthermore, this significant decrease in between groups 1 and 2, 1 and 3, 1 and 4 were observed in groups fed the processed garlic-supplemented diet (P <0.05), so the plasma LDL in treated groups decreased significantly, compared with those of I and II groups. Finally, LDL-cholesterol did show significant change and, demonstrating that dietary supplementation with processed garlic improved lipid profiles (Fig. 2)(Tables 1 and 3).
Fig. 2

Effect of garlic extracts (200 and 400 mg/kg) on serum LDL levels in comparison with the control and hypercholesterolemic groups for 4 weeks on the activity of LDL. Note that statistically significant difference from the control group with other groups . Bars are expressed as mean ± SEM (n = 10). P < 0.05

Plasma lipid profiles of HDL-c level

First stage; between 1–15 days (2 weeks): Table 4 and 5 indicates that between groups 1 and 2, 2 and 4, 5 and 6 created a significant increase in serum HDL-C (P <0/05) and a significant increase in the serum HDL-C level in comparison with I and II groups,the other expression, serum levels of HDL-cholesterol were also increased in the garlic supplemented group compared to those in the control group, there was statistically significant difference in lipid profile among various groups at the beginning of the study. A significant (p <0.05) increase in the level of HDL was observed on IP administration of HDL-c. By comparing the different animal groups, it was observed that rats which received garlic extracts showed the utmost reduction in serum HDL-C levels compared to those which received garlic alone (Fig. 3) (Tables 4 and 5).
Fig. 3

Effect of garlic extracts (200 and 400 mg/kg) on serum HDL levels in comparison with the control and hypercholesterolemic groups for 2 weeks on the activity of HDL. Note that statistically significant difference from the control group with other groups . Bars are expressed as mean ± SEM (n = 10). P < 0.05

Second stage; between 1–30 days (4 weeks): Table 4 and 6 demonstrates that between groups 2 and 3, 2 and 4, as well as groups 1 and 3, 2 and 3 a significant increase in serum HDL-C in comparison with I and II groups (P <0/05). In total, in treated group, a significant increase (p < 0.05) in serum HDL levels was detected compared to I and II groups. To warp up, the test group had significantly lower plasma concentrations of LDL-C, in comparison with I and II group. While the HDL-C level was significantly increased in the treated group with garlic in comparison with rats fed a high-fat diet. Our results suggest that administration of high doses of garlic extracts shows protective effects on HDL in rats with high LDL intake (Fig. 4)(Tables 4 and 6).
Fig. 4

Effect of garlic extracts (200 and 400 mg/kg) on serum HDL levels in comparison with the control and hypercholesterolemic groups for 2 weeks on the activity of HDL. Note that statistically significant difference from the control group with other groups.* Significant as compared to control group with treatment groups. Bars are expressed as mean ± SEM (n = 10). P < 0.05

Discussion

Natural remedies have been investigated for centuries for a wide variety of ailments. Among them, garlic has received special attention for its beneficial effects [3036]. Common available garlic preparations in the form of garlic oil, garlic powder and pills are widely used for certain therapeutic purposes, including lowering blood pressure and improving lipid profile [3739]. Despite the impressive effects of garlic, most studies are limited by lack of controlled methods and by the use of reparations with unknown amounts and chemical identification of the active ingredient. Therefore this study was designed to examine the effects of raw and boiled garlic and their aqueous extracts on lipid, antioxidant and protein status in serum of rats. For this purpose, Wistar rats were fed diets with garlic and cholesterol supplements.

This study has shown that administration of 200 mg/kg/bw, especially 400 mg/kg/bw dietary garlic significantly attenuated serum LDL levels and increased HDL levels in when fed 1 % cholesterol in the fed rats. The significant reduction in the ratio of LDL to HDL/LDL with garlic suggests potential health benefits of garlic supplementation in reduction of coronary artery disease and/or atherosclerosis and/or similar to those described in the field malignant cholesterol diseases. Our findings were in agreement with other studies, which announced that garlic consumption increased HDL-C level in hyperlipidemic patients [7], animals [40], and patients with coronary artery disease [41]. When garlic supplements was added into the diet at a concentration of 1 %, LDL-C level was decreased and HDL-C level were increased in rabbits [42], resulting in a decrease in the LDL-C/HDL-C ratio. Moreover, our observations reveal that the dietary garlic extracts may have cardiovascular diseases protection effects by regulating the LDL-C/HDL-C ratio.

Furthermore, in vivo and in vitro studies in recent years have demonstrated that garlic has cholesterol and triglyceride-lowering, antibacterial, hypoglycemic, hypotensive potential and anti-aggregatory properties [24, 4345]. The effects of garlic on serum lipid levels have been investigated in human and animal models and indicate inconsistency in the reported results [46],which according to these findings can be expressed that our results is exactly in agreement with those mentioned. and, when compared to groups I and II, the significant improvement of lipid profiles in group III and IV rats treated simultaneously with garlic extracts agrees with the previous studies that garlic is a hypolipidemic agent [47] that can help in decreasing the level of LDL-C and in increasing the level of HDL-C. In parallel to, in hypertensive patients, Durak et al. reported that garlic extract supplementation improves blood lipid profile, strengthens blood antioxidant potential and decreases the level of malondialdehyde in blood samples [48], and also, another study by Bordia et al., showed that in patients suffering from coronary artery disease, administration of garlic significantly decreased serum LDL and increased HDL[41]. In a human study, supplementation with raw garlic, powdered garlic, or aged garlic extract (4 g/day) for 6 months significantly lowered LDL-C and other plasma lipid levels in adults with moderate hypercholesterolemia [49]. Our findings in rats provide further support for the anti-hyperlipidemic, and anti-hypercholesterolemic of processed garlic products and garlic exhibited remarkable anti-hyperlipidemic action by decreasing the levels of LDL-C in plasma for groups control and % 1 fed with cholesterol diet and increasing the level of HDL for groups with doses 200 mg/kg and 400 mg/kg, respectively. Although significant reductions in blood cholesterol and triglyceride levels were found in some studies when garlic extract or powder were utilized, no satisfactory agreement has been reached on this kind of clinical and experimental data[49].

Conclusions

In conclusion, the high doses of garlic extracts ameliorated plasma lipid profiles by decreasing the LDL-C level and increasing the HDL-C level in high-fat fed rats. Therefore, our findings revealed that the garlic extract treatment can lower blood cholesterol level, such as LDL and can improve blood lipid profile to a significant extent, such as HDL. Finally, it has been recommended that extracts such as garlic that are rich in anti-hyperlipidemic, and anti-hypercholesterolemic contents may confer beneficial effects in this regard to atherosclerotic processes.

Notes

Declarations

Acknowledgments

We thank Dr. Fathi language editing company for their excellent language editing work for this manuscript.

Authors’ Affiliations

(1)
Department of Agricultural Biotechnology, Sari Agricultural Sciences and Natural Resources University
(2)
Shahid Beheshti University of Medical Sciences
(3)
Department of Biochemistry, College of Science, Kurdistan Science and Research Branch, Islamic Azad University
(4)
Danesh Pathobiology Laboratory
(5)
Shahid Abbas Abdollahi, Molecular Biology Research Center of Shahid Mahallati Hospital
(6)
Department of Legal Medicine, AJA University of Medical Sciences
(7)
Baqiyatallah University of Medical Sciences
(8)
Department of Infectious Diseases, AJA University of Medical Sciences

References

  1. McKenney JM. Pharmacotherapy of dyslipidemia. Cardiovasc Drugs Ther. 2001;15(5):413–22.View ArticlePubMedGoogle Scholar
  2. Castelli WP, Anderson K, Wilson PW, Levy D. Lipids and risk of coronary heart disease. The Framingham Study. Ann Epidemiol. 1992;2(1–2):23–8.View ArticlePubMedGoogle Scholar
  3. Shimokawa H, Vanhoutte PM. Impaired endothelium-dependent relaxation to aggregating platelets and related vasoactive substances in porcine coronary arteries in hypercholesterolemia and atherosclerosis. Circ Res. 1989;64(5):900–14.View ArticlePubMedGoogle Scholar
  4. Ozaki MR, de Almeida EA. Evolution and involution of atherosclerosis and its relationship with vascular reactivity in hypercholesterolemic rabbits. Exp Toxicol Pathol. 2013;65(3):297–304.View ArticlePubMedGoogle Scholar
  5. Law MR. Lowering heart disease risk with cholesterol reduction: evidence from observational studies and clinical trials. Eur Heart J Suppl. 1999;1:S3–8.Google Scholar
  6. Shaten BJ, Kuller LH, Neaton JD. Association between baseline risk factors, cigarette smoking, and CHD mortality after 10.5 years. MRFIT Research Group. Prev Med. 1991;20(5):655–9.View ArticlePubMedGoogle Scholar
  7. Mahmoodi M, Islami MR, Asadi Karam GR, Khaksari M, Sahebghadam Lotfi A, Hajizadeh MR, et al. Study of the effects of raw garlic consumption on the level of lipids and other blood biochemical factors in hyperlipidemic individuals. Pak J Pharm Sci. 2006;19(4):295–8.PubMedGoogle Scholar
  8. Gorinstein S, Leontowicz H, Leontowicz M, Drzewiecki J, Najman K, Katrich E, et al. Raw and boiled garlic enhances plasma antioxidant activity and improves plasma lipid metabolism in cholesterol-fed rats. Life Sci. 2006;78(6):655–63.View ArticlePubMedGoogle Scholar
  9. Thomas GPS, Sankar SKS, Bobby Z. Study the effect of s-methyl L-cysteine on lipid metabolism in an experimental model of diet induced obesity. J Clin Diagn Res. 2013;7(11):2449–51.PubMedPubMed CentralGoogle Scholar
  10. Sohn CW, Kim H, You BR, Kim MJ, Kim HJ, Lee JY, et al. High temperature- and high pressure-processed garlic improves lipid profiles in rats fed high cholesterol diets. J Med Food. 2012;15(5):435–40.View ArticlePubMedPubMed CentralGoogle Scholar
  11. Heidarian E, Jafari-Dehkordi E, Seidkhani-Nahal A. Effect of garlic on liver phosphatidate phosphohydrolase and plasma lipid levels in hyperlipidemic rats. Food Chem Toxicol. 2011;49(5):1110–4.View ArticlePubMedGoogle Scholar
  12. Sangeetha T, Darlin QS. Preventive effect of S-allyl cysteine sulfoxide (alliin) on cardiac marker enzymes and lipids in isoproterenol-induced myocardial injury. J Pharm Pharmacol. 2006;58(5):617–23.View ArticlePubMedGoogle Scholar
  13. Slowing K, Ganado P, Sanz M, Ruiz E, Tejerina T. Study of garlic extracts and fractions on cholesterol plasma levels and vascular reactivity in cholesterol-fed rats. J Nutr. 2001;131(3s):994S–9.PubMedGoogle Scholar
  14. Singh DK, Porter TD. Inhibition of sterol 4alpha-methyl oxidase is the principal mechanism by which garlic decreases cholesterol synthesis. J Nutr. 2006;136(3 Suppl):759S–64.PubMedGoogle Scholar
  15. Sumioka I, Hayama M, Shimokawa Y, Shiraishi S, Tokunaga A. Lipid-lowering effect of monascus garlic fermented extract (MGFE) in hyperlipidemic subjects. Hiroshima J Med Sci. 2006;55(2):59–64.PubMedGoogle Scholar
  16. Cellini L, Di Campli E, Masulli M, Di Bartolomeo S, Allocati N. Inhibitions of Helicobacter pylori by garlic extract (Allium sativum). FEMS Immunol Med Microbiol. 1996;13(4):273–7.View ArticlePubMedGoogle Scholar
  17. Bordia A, Verma SK, Khabia BL, Vyas A, Rathore AS, Bhu N, et al. The effective of active principle of garlic and onion on blood lipids and experimental atherosclerosis in rabbits and their comparison with clofibrate. J Assoc Physicians India. 1977;25(8):509–16.PubMedGoogle Scholar
  18. Foushee DB, Ruffin J, Banerjee U. Garlic as a natural agent for the treatment of hypertension: a preliminary report. Cytobios. 1982;34:145–52.PubMedGoogle Scholar
  19. Mcmahon FG, Vargas R. Can garlic lower blood pressure? A pilot study. Pharmacotherapy. 1993;13:406–7.PubMedGoogle Scholar
  20. Eilat S, Oestraicher Y, Rabinkov A, Ohad D, Mirelman D, Battler A, et al. Alteration of lipid profile in hyperlipidemic rabbits by allicin, an active constituent of garlic. Coron Artery Dis. 1995;6(12):985–90.PubMedGoogle Scholar
  21. Yeh YY, Yeh SM. Garlic reduces plasma lipids by inhibiting hepatic cholesterol and triacylglycerol synthesis. Lipids. 1994;29(3):189–93.View ArticlePubMedGoogle Scholar
  22. Abdalla FH, Bellé LP, De Bona KS, Bitencourt PE, Pigatto AS, Moretto MB. Allium sativum L. extract prevents methyl mercury-induced cytotoxicity in peripheral blood leukocytes (LS). Food Chem Toxicol. 2010;48(1):417–21.View ArticlePubMedGoogle Scholar
  23. Azuma K, Minami Y, Ippoushi K, Terao J. Lowering effects of onion intake on oxidative stress biomarkers in streptozotocin-induced diabetic rats. J Clin Biochem Nutr. 2007;40(2):131–40.View ArticlePubMedPubMed CentralGoogle Scholar
  24. Lau BH. Suppression of LDL oxidation by garlic compounds is a possible mechanism of cardiovascular health benefit. J Nutr. 2006;136(3 Suppl):765S–8.PubMedGoogle Scholar
  25. Sharma V, Sharma A, Kansal L. The effect of oral administration of Allium sativum extracts on lead nitrate induced toxicity in male mice. Food Chem Toxicol. 2010;48(3):928–36.View ArticlePubMedGoogle Scholar
  26. Banerjee SK, Maulik SK. Effect of garlic on cardio-vascular disorders: a review. Nutr J. 2002;1:1–14.View ArticleGoogle Scholar
  27. Rahman K, Lowe GM. Garlic and cardiovascular disease: A critical review. J Nutr. 2006;136(3):736S–40.PubMedGoogle Scholar
  28. Yu TH, Wu CM, Liou YC. Volatile compounds from garlic. J Agric Food Chem. 1989;37:725–30.View ArticleGoogle Scholar
  29. Yu TH, Wu CM, Chen SY. Effects of pH adjustment and heat treatment on the stability and the formation of volatile compounds of garlic. J AgricFood Chem. 1989;37:730–4.View ArticleGoogle Scholar
  30. Kandziora J. Antihypertensive effectiveness and tolerance of a garlic medication. Arzl Forsch. 1988;1:1–8.Google Scholar
  31. Kandziora J. The blood pressure lowering and lipid lowering effect of a garlic preparation in combination with a diuretic. Arzl Forsch. 1988;3:1–8.Google Scholar
  32. Auer W, Eiber A, Hertkorn E, Hoehfeld E, Koehrle U, Lorenz A, et al. Hypertension and hyperlipidemia: garlic helps in mild cases. Br J Clin Pract. 1990;69(suppl):3–6.Google Scholar
  33. Vorberg G, Schneider B. Therapy with garlic: results of a plasebocontrolled double-blind study. Br J Clin Pract Symp. 1990;69(suppl):7–11.Google Scholar
  34. Santos OS, Grunwald J. Effects of garlic powder tablets on blood lipids and blood pressures. A six month placebo-controlled double blind study. Br J Clin Res. 1993;4:37–44.Google Scholar
  35. Kleijnen J, Knipschild P, Ter Riet G. Garlic, onion and cardiovascular risk factors. A review of the evidence from human experiments with emphasis on commercially available preparations. Br J Clin Pharmacol. 1989;28:535–44.View ArticlePubMedPubMed CentralGoogle Scholar
  36. Elkayam A, Mirelman D, Peleg E, Wilchek M, Miron T, Rabinkov A, et al. The effects of allicin on weight in fructose-induced hyperinsulinemic, hyperlipidemic, hypertensive rats. Am J Hypertens. 2003;16(12):1053–6.View ArticlePubMedGoogle Scholar
  37. Stevinson C, Pittler MH, Ernst E. Garlic for treating hypercholesterolemia. A meta-analysis of randomized clinical trials. Ann Intern Med. 2000;133(6):420–9.View ArticlePubMedGoogle Scholar
  38. Abdel-Wahhab MA, Aly SE. Antioxidants and radical scavenging properties of vegetable extracts in rats fed aflatoxin-contaminated diet. J Agric Food Chem. 2003;51(8):2409–14.View ArticlePubMedGoogle Scholar
  39. Thomson M, Al-Qattan KK, Bordia T, Ali M. Including garlic in the diet may help lower blood glucose, cholesterol, and triglycerides. J Nutr. 2006;136:800S–2.PubMedGoogle Scholar
  40. Bordia A, Verma SK, Srivastava KC. Effect of garlic (Allium sativum) on blood lipids, blood sugar, fibrinogen and fibrinolytic activity in patients with coronary artery disease. Prostaglandins Leukotrienes Essent. Fatty Acids. 1998;58:257–63.View ArticleGoogle Scholar
  41. Kwon MJ, Song YS, Choi MS, Park SJ, Jeong KS, Song YO. Cholesteryl ester transfer protein activity and atherogenic parameters in rabbits supplemented with cholesterol and garlic powder. Life Sci. 2003;72:2953–64.View ArticlePubMedGoogle Scholar
  42. Agarwal KC. Therapeutic actions of garlic constituents. Med Res Rev. 1996;16(1):111–24.View ArticlePubMedGoogle Scholar
  43. Aviello G, Abenavoli L, Borrelli F, Capasso R, Izzo AA, Lembo F, et al. Garlic: empiricism or science? Nat Prod Commun. 2009;4(12):1785–96.PubMedGoogle Scholar
  44. Gorinstein S, Jastrzebski Z, Namiesnik J, Leontowicz H, Leontowicz M, Trakhtenberg S. The atherosclerotic heart disease and protecting properties of garlic: contemporary data. Mol Nutr Food Res. 2007;51(11):1365–81.View ArticlePubMedGoogle Scholar
  45. Ali M, Al-Qattan KK, Al-Enezi F, Khanafer RM, Mustafa T. Effect of allicin from garlic powder on serum lipids and blood pressure in rats fed with a high cholesterol diet. Prostaglandins Leukot Essent Fatty Acids. 2000;62(4):253–9.View ArticlePubMedGoogle Scholar
  46. Auer W, Eiber A, Hertkorn E, Koehrle U, Lorenz A. Hypertension and hyperlipidemia: garlic helps in mild cases. Br J Clin Prac Suppl. 1990;69:3–6.Google Scholar
  47. Durak I, Kavutcu M, Aytaç B, Avci A, Devrim E, Ozbek H, et al. Effects of garlic extract consumption on blood lipid and oxidant/antioxidant parameters in humans with high blood cholesterol. J Nutr Biochem. 2004;15:373–7.View ArticlePubMedGoogle Scholar
  48. Gardner CD, Lawson LD, Block E, Chatterjee LM, Kiazand A, Balise RR, et al. Effect of raw garlic commercial garlic supplements on plasma lipid concentrations in adults with moderate hypercholesterolemia: a randomized clinical trial. Arch Intern Med. 2007;167:346–53.View ArticlePubMedGoogle Scholar
  49. Silagy CA, Neil HAW. A meta-analysis of the effect of garlic on blood pressure. J Hypertens. 1994;12:463–8.View ArticlePubMedGoogle Scholar

Copyright

© Ebrahimi et al. 2015

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement